Healthcare Buy-Sell Agreements

Healthcare Buy-Sell Agreements in California: Protecting Multi-Physician Practices

A healthcare buy-sell agreement is arguably the single most important governance document for any multi-physician practice in California—and the one most frequently neglected. Every medical corporation, physician partnership, or multi-member medical LLC with two or more physician-owners faces an inevitable reality: at some point, one of the owners will leave the practice, whether through retirement, disability, death, voluntary departure, termination, loss of license, bankruptcy, or divorce. Without a properly drafted buy-sell agreement, any of these triggering events can produce a crisis—disputes over valuation, fights about who may purchase shares, regulatory violations arising from shares passing to unlicensed individuals, and practice paralysis during the most operationally vulnerable period.

California's regulatory environment makes healthcare buy-sell agreements more complex than their counterparts in non-healthcare businesses. The corporate practice of medicine (CPOM) doctrine restricts who may own shares in a professional medical corporation: under Corporations Code §13401 and §13407, only licensed physicians (or other authorized healing arts professionals, depending on the corporation type) may hold shares. If a physician-owner dies and the shares pass to an unlicensed heir through intestacy or a will, the practice faces an immediate CPOM compliance problem. If a physician loses a medical license, the shares must be redeemed or transferred to an eligible licensee. These constraints make a comprehensive buy-sell agreement not merely advisable but legally necessary.

Bay Legal PC drafts, reviews, and negotiates healthcare buy-sell agreements for California medical corporations, physician partnerships, and multi-member medical LLCs. We structure these agreements to address the full spectrum of triggering events, establish fair and workable valuation mechanisms, ensure CPOM compliance, and integrate with the practice's broader succession and governance framework.

Section 1: Triggering Events in Healthcare Buy-Sell Agreements

Defining When a Buyout Obligation Arises

The effectiveness of a buy-sell agreement depends on the precision with which it defines the events that trigger a purchase or redemption obligation. In the healthcare context, triggering events must address not only the standard business scenarios—death, disability, and retirement—but also healthcare-specific contingencies that have no parallel in general commercial practice.

Death of a physician-owner is the most straightforward triggering event, but it raises immediate CPOM concerns. When a physician-owner dies, shares may pass to the physician's estate or heirs under intestacy or a will. Because unlicensed individuals cannot hold shares in a professional medical corporation under Corporations Code §13407, the buy-sell agreement must create a mandatory obligation—either for the corporation to redeem the shares or for the remaining physician-owners to purchase them—within a defined timeframe. This obligation is typically funded through life insurance on each owner's life. Disability presents more complex drafting challenges: the agreement must define "disability" with specificity (total disability, partial disability, duration thresholds), specify how disability is determined (treating physician certification, independent medical examination, insurer determination), and establish the timeline and terms of a mandatory buyout once the disability threshold is met.

Voluntary departure, retirement, and termination for cause each require distinct treatment. Voluntary departure provisions typically include a notice period (often 90 to 180 days), a defined valuation date, and a payment schedule. Retirement provisions may include age or years-of-service thresholds and may provide for more favorable payment terms than a voluntary departure. Termination for cause—defined to include material breach of the shareholder agreement, fraud, substance abuse, or conduct detrimental to the practice—typically triggers a mandatory buyout at a discounted valuation to reflect the departing physician's culpability. Loss of medical license is a uniquely healthcare-specific trigger: because an unlicensed person cannot hold shares in a medical professional corporation, the agreement must require immediate redemption or transfer, regardless of the circumstances of the license revocation or suspension. Bankruptcy and divorce round out the standard triggering events, with the agreement typically providing the practice with a right of first refusal before shares can be transferred to a creditor or former spouse.

Section 2: Valuation Mechanisms

Getting the Valuation Right to Prevent Disputes

Valuation disputes are the leading source of litigation in physician buy-sell agreements, and the costs of getting it wrong—both financial and operational—can be devastating. A well-drafted buy-sell agreement establishes the valuation methodology at the outset, when all parties are negotiating in good faith, rather than leaving valuation to be determined at the time of a triggering event, when interests have diverged and emotions may be elevated.

The principal valuation mechanisms used in healthcare buy-sell agreements are formula-based approaches, appraised value approaches, fixed-price approaches, and hybrid approaches. A formula-based valuation uses a predetermined formula—typically a multiple of trailing revenue, adjusted net income, or EBITDA—applied to the practice's financial results as of the valuation date. This approach has the advantages of objectivity, predictability, and low cost, but it may fail to capture changes in market conditions or practice-specific circumstances. An appraised value approach requires an independent valuation by a qualified healthcare appraiser at the time of the triggering event, using standard valuation methodologies (income, market, and asset approaches). This produces the most accurate result but adds cost and delay, and introduces subjectivity through the appraiser's judgment.

A fixed-price approach sets a specific dollar value for each owner's interest, typically updated annually by agreement of the owners. While simple, this approach is vulnerable to stale valuations if the owners fail to update the price—a common occurrence that can result in a buyout price that is dramatically above or below fair market value. Hybrid approaches combine elements: for example, a formula-based preliminary valuation with a right to request a formal appraisal if any party objects to the formula result, or a fixed price with an annual true-up mechanism. For medical practices, the valuation mechanism must also address the distinction between personal goodwill and enterprise goodwill, the treatment of accounts receivable, the allocation of work-in-progress revenue, and the impact of provider-dependent revenue on the practice's going-concern value.

Section 3: Funding Mechanisms and Transfer Restrictions

Funding the Buyout and Ensuring CPOM-Compliant Share Transfers

A buy-sell agreement is only as good as the practice's ability to fund the buyout when a triggering event occurs. The most common funding mechanisms are life insurance (for death triggers), disability buy-out insurance (for disability triggers), installment payments from practice cash flow (for voluntary departures and retirements), and practice reserves accumulated over time. Many agreements employ a combination of these mechanisms, with insurance providing liquidity for sudden events and installment payments spreading the cost of planned departures.

For the death trigger, the practice or the remaining owners typically maintain life insurance policies on each owner's life in an amount equal to or approximating the estimated buyout price. The structure of the insurance—whether owned by the corporation (entity redemption) or by the individual co-owners (cross-purchase)—has significant tax implications. In a cross-purchase arrangement, the purchasing owners receive a cost basis in the acquired shares equal to the purchase price, which can reduce capital gains tax on a future sale of those shares. In an entity redemption, the corporation redeems the shares using corporate-owned life insurance, but the remaining owners generally do not receive a stepped-up basis in their shares. For C corporations, this basis differential can be material; for S corporations and pass-through entities, the impact is typically less significant. Tax counsel should be consulted in selecting the insurance structure, as the optimal approach depends on the entity type, the number of owners, and the long-term exit strategy.

Transfer restrictions are the CPOM compliance backbone of the buy-sell agreement. The agreement must prohibit the transfer of shares to any person who does not hold a valid California medical license (or the applicable healing arts license for the corporation type). This restriction applies to transfers by operation of law (such as inheritance or divorce decree), involuntary transfers (such as creditor seizure in bankruptcy), and voluntary transfers (such as a sale to a third party). The agreement should grant the corporation and/or the remaining owners a right of first refusal on any proposed transfer, with a mandatory redemption obligation triggered by any event that would result in shares being held by an unlicensed person. Corporations Code §13407 reinforces this restriction, providing that the issuance or transfer of shares in a professional corporation to a disqualified person is void.

Section 4: Non-Compete Considerations, Disability Provisions, and Tax Implications

Navigating SB 351, Disability Definitions, and Tax Structure in Buy-Sell Agreements

California's prohibition on non-compete agreements under BPC §16600 directly affects the drafting of buy-sell agreements. A buy-sell agreement cannot condition the buyout payment on the departing physician's agreement not to compete with the practice. This prohibition applies to voluntary departures, terminations for cause, retirements, and disability buyouts. The only exception is the sale-of-business exception under BPC §16601, which applies when a physician-owner sells the goodwill of the business or all ownership interests—a structure that may be available in a complete practice sale but is rarely applicable to a single-owner buyout within an ongoing multi-physician group.

SB 351, effective January 1, 2026, reinforces this prohibition in the context of practices involving private equity groups or hedge funds. Contracts between such entities and physician practices cannot include clauses barring departing providers from competing. Even outside the SB 351 context, including a non-compete clause in a buy-sell agreement creates legal risk: the clause is void under Section 16600, its inclusion may be used as evidence of overreach in a buyout dispute, and the physician who is subjected to the unenforceable clause may bring a claim for damages and attorney's fees under BPC §16600.5.

Disability provisions require particular care in the healthcare context. The buy-sell agreement must define "disability" with sufficient specificity to avoid disputes—typically referencing the physician's inability to perform the essential functions of medical practice for a specified duration (e.g., 90 consecutive days or 120 days within any 12-month period). The determination mechanism should be objective: certification by the physician's treating provider, confirmation by an independent medical examiner selected through a defined process, or a determination by the disability insurance carrier. The agreement should also address partial disability (where the physician can work in a reduced capacity), the transition period between the onset of disability and the mandatory buyout trigger, and the impact of a disability buyout on the physician's medical license and malpractice coverage.

At the overview level, the tax implications of buy-sell structures vary significantly depending on whether the agreement is structured as a cross-purchase or entity redemption, the entity type (C corporation, S corporation, or partnership/LLC), and the allocation of the purchase price among asset categories including goodwill, tangible assets, and the covenant not to compete (to the extent one is permissible under the sale-of-business exception). Because tax treatment is highly fact-specific and may involve both federal and California state tax consequences, physician-owners should consult with qualified tax counsel when structuring or revising a buy-sell agreement.

Steps / HowTo Section:

How to Establish a Healthcare Buy-Sell Agreement for Your Practice

1. Identify all physician-owners and their ownership interests. Document each owner's percentage interest, capital contributions, license status, and any existing agreements (employment agreements, shareholder agreements, operating agreements) that may affect the buy-sell structure.

1. Define all triggering events. Work with counsel to draft precise definitions for each triggering event: death, disability (including the definition of disability and the determination mechanism), retirement, voluntary departure, termination for cause (with defined grounds), loss of medical license, bankruptcy, and divorce. Ensure that each trigger includes a timeline for initiating and completing the buyout.

1. Select and document the valuation methodology. Choose a formula-based, appraised value, fixed-price, or hybrid approach. If using a fixed-price approach, commit to an annual update schedule. If using a formula, specify the financial metrics, the lookback period, and any adjustments for personal goodwill, accounts receivable, or provider-dependent revenue.

1. Establish funding mechanisms. Procure life insurance and disability buy-out insurance on each owner. Determine whether policies will be owned by the corporation (entity redemption) or by individual co-owners (cross-purchase). Coordinate the insurance amounts with the estimated buyout valuations and update coverage as valuations change.

1. Draft CPOM-compliant transfer restrictions. Prohibit all transfers to unlicensed persons. Include rights of first refusal, mandatory redemption provisions for disqualifying events, and drag-along/tag-along rights where appropriate. Ensure compliance with Corporations Code §§13401 and 13407.

1. Address non-compete compliance. Do not include non-compete clauses as a condition of the buyout. Structure post-departure provisions around patient transition protocols, confidentiality obligations, and—where applicable—the narrow sale-of-business exception under BPC §16601. Ensure compliance with SB 351 if private equity or hedge fund entities are involved.

1. Execute, fund, and maintain the agreement. All physician-owners should sign the buy-sell agreement simultaneously. Fund insurance policies immediately. Establish an annual review cycle to update valuations, insurance coverage, and triggering event definitions as the practice evolves. Revisit the agreement whenever a new physician-owner joins or an existing owner's circumstances change.

Bay Legal PC drafts, reviews, and negotiates healthcare buy-sell agreements for California medical corporations, physician partnerships, and multi-member medical LLCs. Our services include structuring cross-purchase and entity redemption arrangements; defining triggering events and valuation mechanisms tailored to the practice's size, specialty, and ownership structure; coordinating with insurance professionals on life and disability buy-out insurance; ensuring CPOM-compliant transfer restrictions under Corporations Code §§13401 and 13407; integrating non-compete compliance under BPC §16600 and SB 351; advising on tax structure considerations in coordination with the practice's tax counsel; and conducting periodic reviews and updates of existing buy-sell agreements. We serve multi-physician practices across California.

Q: Why does every multi-physician practice in California need a buy-sell agreement?

A: A buy-sell agreement is essential because of California's corporate practice of medicine (CPOM) doctrine. Under Corporations Code §13407, only licensed physicians may hold shares in a professional medical corporation. Without a buy-sell agreement, a physician's death could result in shares passing to unlicensed heirs, creating an immediate CPOM violation. A physician's disability could leave the practice without a mechanism to transition ownership. A departure dispute could paralyze the practice. The buy-sell agreement provides a predetermined, legally enforceable framework for handling every ownership transition scenario—protecting the practice, the remaining owners, and the departing physician or the physician's estate.

Q: What is the difference between a cross-purchase and an entity redemption buy-sell structure?

A: In a cross-purchase arrangement, the remaining physician-owners agree to purchase the departing owner's shares directly. In an entity redemption, the medical corporation itself redeems (buys back) the departing owner's shares. The key practical difference is tax basis: in a cross-purchase, the purchasing owners receive a cost basis in the acquired shares equal to the purchase price, which can reduce capital gains on a future sale. In an entity redemption, the remaining owners' basis in their own shares generally does not increase. For C corporations, this basis differential can be significant. Cross-purchase arrangements become administratively complex as the number of owners increases (requiring each owner to maintain insurance on every other owner), while entity redemptions are simpler to administer. The optimal structure depends on the entity type, the number of owners, and the long-term exit strategy, and should be selected in consultation with tax counsel.

Q: Can a buy-sell agreement include a non-compete clause requiring the departing physician not to compete?

A: No, with a very narrow exception. Under BPC §16600, non-compete agreements are void in California. A buy-sell agreement cannot condition the buyout price, payment terms, or other provisions on the departing physician's agreement not to compete. The only exception is BPC §16601, which permits a non-compete in connection with the genuine sale of a business—where the physician sells all ownership interests or the goodwill of the practice. In a typical multi-physician buy-sell scenario (where one physician departs and the others continue), this exception is rarely applicable. SB 351 further reinforces this prohibition for practices involving private equity or hedge fund entities. Instead of non-competes, practices should structure post-departure provisions around patient transition protocols and narrowly tailored confidentiality agreements.

Q: How should "disability" be defined in a physician buy-sell agreement?

A: The definition of disability should be specific, objective, and tied to the physician's ability to practice medicine. A common formulation defines disability as the physician's inability to perform the essential functions of medical practice for a specified continuous period (e.g., 90 or 180 consecutive days) or for a cumulative period within a defined timeframe (e.g., 120 days within any 12-month period). The determination mechanism should be objective—typically requiring certification by an independent physician selected through a defined process (such as mutual agreement or each party selecting a physician with the two selecting a third). The buy-sell agreement should also address partial disability, the transition period before a mandatory buyout is triggered, and coordination with any disability insurance coverage funding the buyout.

Q: What happens if a physician-owner loses their medical license?

A: Loss of medical license is a critical triggering event in a healthcare buy-sell agreement because Corporations Code §13407 prohibits unlicensed persons from holding shares in a professional medical corporation. If a physician-owner's license is revoked or suspended, the buy-sell agreement should require immediate mandatory redemption of that physician's shares by the corporation or purchase by the remaining owners. The agreement should specify the valuation method, payment terms, and timeline for completing the redemption. Without this provision, the practice faces a CPOM compliance violation—the unlicensed physician would be holding shares in violation of California law, potentially triggering Medical Board enforcement action and jeopardizing the practice's corporate status.

Q: How often should a buy-sell agreement be reviewed and updated?

A: At minimum, annually. The annual review should include an update to the practice valuation (whether recalculated by formula or formally re-appraised), a review of insurance coverage levels to ensure they align with current valuations, and any necessary amendments to reflect changes in ownership (new physician-owners joining or existing owners departing). Beyond the annual cycle, the buy-sell agreement should be revised whenever there is a material change in the practice—such as a significant increase or decrease in revenue, the addition of a new practice location, a change in entity structure, or a change in applicable law (such as SB 351's effective date of January 1, 2026). Stale buy-sell agreements are a leading cause of buyout disputes.

Q: What role does life insurance play in funding a buy-sell agreement?

A: Life insurance is the primary funding mechanism for death-triggered buyouts in physician buy-sell agreements. Each physician-owner's life is insured in an amount approximating the estimated buyout price for that owner's interest. When a physician-owner dies, the insurance proceeds provide immediate liquidity to fund the purchase of the deceased owner's shares—whether by the corporation (entity redemption) or by the remaining owners (cross-purchase). Without life insurance funding, the practice would need to fund the buyout from operating cash flow or reserves, which can create severe financial strain and may require installment payments over years. The insurance policy ownership structure (corporate-owned vs. individually owned) affects the tax treatment of proceeds and should be coordinated with the buy-sell structure and the practice's overall tax planning.

Internal Links

• Medical Business & Healthcare Law
• Buying or Selling a Medical Practice
• Healthcare Non-Compete Compliance
• Business Formation
• Contract Law

External Links

• Medical Board of California
• California Legislative Information
• IRS